Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer
about
The effect of radiation on the immune response to cancersRadiation as immunomodulator: implications for dendritic cell-based immunotherapyCHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.The tumor-immune microenvironment and response to radiation therapyTargeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancerPutative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.The role of the ubiquitin/proteasome system in cellular responses to radiation.IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.Immunomodulatory effects of radiation: what is next for cancer therapy?Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection.Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports.The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination.Radiation enhances the anti-tumor effects of vaccinia-p53 gene therapy in glioma.Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors.Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells.Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.Combining radiation plus immunotherapy to improve systemic immune response.
P2860
Q26995372-ED48EF60-729A-47D7-800F-33813FC69809Q27025756-052B7443-0B5E-46A3-A7CB-9A69F342FB5BQ33755370-5A425952-F80A-4027-918C-67708D6D5336Q33830089-AF677517-A516-4D87-8BBB-E7EB3045BE92Q34444598-D505AF11-4684-44BE-925B-668D2983CD24Q34647792-31247223-C782-4814-9EA8-0D9E0D6F97F4Q34924937-19E3E18C-FC64-4CB4-93C0-81594F3494D8Q35001648-735F1C81-235D-4539-9C54-75587A7B7C6BQ35208807-E4DDFB93-BB98-4AC6-B03E-0A8AEA75E45DQ35369944-C32724BC-1E1A-4219-8F4C-FC066D2F3F2CQ36568984-5A5DF509-0FE7-4772-9136-6680C39FD31EQ36746004-740B4D5D-8339-472E-B035-A95657DCB1C5Q36959955-05C482D8-1992-4B8F-A57E-8B7E1EEAB614Q37051019-9A629704-160B-4A02-8E9A-82C0CA3E9F19Q37198014-C025DC3A-B1FE-4BBB-BA44-D0E9BB52AC18Q37981764-E1969076-902D-4ECB-BEB7-0AAF5989DB8BQ38122205-CC9EB2ED-1BD0-412D-87DC-3B9009BFCDB8Q38654155-9EC5BB9F-554F-4C8D-996B-9298FA22DAB5Q39459780-EF223CAE-F5D7-4F10-B45F-0A6F1BFC5679Q39838049-11DE4C70-3A89-4412-9C45-7B4EBF185C3CQ40421152-581A0600-5060-4C47-84C5-70BD0849CA49Q41282716-8479FFFE-098F-4B13-8D5A-52882403A667Q41577994-629FD261-34BE-491F-AEE8-693D79483356Q42278547-469D75BF-F927-41DF-A8BF-1887445A1217Q44461360-FD3FDC3B-5010-4FFB-82EE-4661A3C8A01CQ48248569-5B6C4D73-B1D9-4487-B2C1-852EDA91AC74Q53411447-32A395DF-E3B7-4170-9E18-B90FF258F94EQ53600528-B73D6709-BD20-4341-A9F2-75DCAB1B357AQ55235684-AE488DBC-4EFC-4269-95A1-7F3F34B2C996
P2860
Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@ast
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@en
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@nl
type
label
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@ast
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@en
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@nl
prefLabel
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@ast
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@en
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@nl
P2093
P2860
P356
P1433
P1476
Sub-lethal radiation enhances ...... use model of pancreatic cancer
@en
P2093
Douglas Hanahan
Dylan Daniel
Zhu Alexander Cao
P2860
P2888
P356
10.1186/1471-2407-2-11
P407
P577
2002-05-03T00:00:00Z
P5875
P6179
1042800536